Quick Answer
TuHURA Biosciences, Inc./NV reported Research And Development Expense of $20.53 million for the year ending 2025.
- TuHURA Biosciences, Inc./NV showed an increase of +54.0% in Research And Development Expense from 2024 to 2025.
- This data is from TuHURA Biosciences, Inc./NV's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2011 to 2025), TuHURA Biosciences, Inc./NV's Research And Development Expense has grown by 1,853.4%.
- Historical annual values: Fiscal year 2025: $20.53 million | Fiscal year 2024: $13.34 million | Fiscal year 2024: $2.66 million | Fiscal year 2023: $9.40 million | Fiscal year 2023: $9.31 million | Fiscal year 2022: $15.17 million | Fiscal year 2021: $11.82 million | Fiscal year 2020: $3.63 million | Fiscal year 2019: $3.66 million | Fiscal year 2018: -$7.13 million | Fiscal year 2017: -$5.00 million | Fiscal year 2016: $3.36 million | Fiscal year 2015: -$2.56 million | Fiscal year 2014: -$2.12 million | Fiscal year 2013: $2.34 million | Fiscal year 2012: $1.55 million | Fiscal year 2011: $1.05 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: